Newtyn Management, LLC Atea Pharmaceuticals, Inc. Transaction History
Newtyn Management, LLC
- $458 Million
- Q2 2024
A detailed history of Newtyn Management, LLC transactions in Atea Pharmaceuticals, Inc. stock. As of the latest transaction made, Newtyn Management, LLC holds 380,000 shares of AVIR stock, worth $1.37 Million. This represents 0.27% of its overall portfolio holdings.
Number of Shares
380,000
Previous 400,000
5.0%
Holding current value
$1.37 Million
Previous $1.62 Million
22.22%
% of portfolio
0.27%
Previous 0.35%
Shares
5 transactions
Others Institutions Holding AVIR
# of Institutions
111Shares Held
51.2MCall Options Held
71.8KPut Options Held
318K-
Black Rock Inc. New York, NY9.12MShares$32.8 Million0.0% of portfolio
-
Bml Capital Management, LLC Zionsville, IN6.38MShares$23 Million15.06% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.44MShares$19.6 Million0.64% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.72MShares$17 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA4.48MShares$16.1 Million1.81% of portfolio
About Atea Pharmaceuticals, Inc.
- Ticker AVIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,258,600
- Market Cap $300M
- Description
- Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...